NMTC

NeuroOne Medical Technol... (NMTC)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:NMTC
DataOraFonteTitoloSimboloCompagnia
10/04/202415:00GlobeNewswire Inc.NeuroOne® CEO Dave Rosa Featured on Bloomberg TechnologyNASDAQ:NMTCNeuroOne Medical Technologies Corporation
09/04/202415:05GlobeNewswire Inc.NeuroOne® Announces First Implant of OneRF™ Ablation ElectrodesNASDAQ:NMTCNeuroOne Medical Technologies Corporation
04/04/202415:00GlobeNewswire Inc.NeuroOne® CEO Dave Rosa Featured on Fox Business Network’s Varney & Co.NASDAQ:NMTCNeuroOne Medical Technologies Corporation
26/03/202414:00GlobeNewswire Inc.NeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation SystemNASDAQ:NMTCNeuroOne Medical Technologies Corporation
08/03/202418:00GlobeNewswire Inc.NeuroOne® to Participate in the 36th Annual Roth ConferenceNASDAQ:NMTCNeuroOne Medical Technologies Corporation
04/03/202420:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NMTCNeuroOne Medical Technologies Corporation
23/02/202423:10GlobeNewswire Inc.NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:NMTCNeuroOne Medical Technologies Corporation
13/02/202422:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NMTCNeuroOne Medical Technologies Corporation
13/02/202422:00GlobeNewswire Inc.NeuroOne® Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate UpdateNASDAQ:NMTCNeuroOne Medical Technologies Corporation
08/02/202421:30GlobeNewswire Inc.NeuroOne® to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13NASDAQ:NMTCNeuroOne Medical Technologies Corporation
31/01/202422:09Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:NMTCNeuroOne Medical Technologies Corporation
29/01/202415:02Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:NMTCNeuroOne Medical Technologies Corporation
29/01/202415:00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:NMTCNeuroOne Medical Technologies Corporation
05/01/202422:16Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:NMTCNeuroOne Medical Technologies Corporation
21/12/202315:35Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:NMTCNeuroOne Medical Technologies Corporation
15/12/202322:39Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:NMTCNeuroOne Medical Technologies Corporation
14/12/202322:15GlobeNewswire Inc.NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:NMTCNeuroOne Medical Technologies Corporation
11/12/202314:00GlobeNewswire Inc.NeuroOne® Receives FDA 510(k) Clearance to Market its OneRF™ Ablation SystemNASDAQ:NMTCNeuroOne Medical Technologies Corporation
07/12/202322:30GlobeNewswire Inc.NeuroOne® to Report Fourth Quarter and Fiscal Year 2023 Financial Results and Provide Corporate Update on December 14NASDAQ:NMTCNeuroOne Medical Technologies Corporation
16/11/202314:00GlobeNewswire Inc.NeuroOne® Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural ProbeNASDAQ:NMTCNeuroOne Medical Technologies Corporation
14/11/202323:15GlobeNewswire Inc.NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:NMTCNeuroOne Medical Technologies Corporation
07/11/202314:00GlobeNewswire Inc.NeuroOne® Provides Progress Update on FDA 510(k) Submission for OneRF™ Ablation SystemNASDAQ:NMTCNeuroOne Medical Technologies Corporation
13/10/202315:30GlobeNewswire Inc.NeuroOne® to Present at the ThinkEquity Conference on October 19, 2023NASDAQ:NMTCNeuroOne Medical Technologies Corporation
06/09/202322:00GlobeNewswire Inc.NeuroOne® to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:NMTCNeuroOne Medical Technologies Corporation
14/08/202322:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NMTCNeuroOne Medical Technologies Corporation
14/08/202322:00GlobeNewswire Inc.NeuroOne® Reports Third Quarter Fiscal Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:NMTCNeuroOne Medical Technologies Corporation
08/08/202322:00GlobeNewswire Inc.NeuroOne® to Report Third Quarter Fiscal Year 2023 Financial Results and Provide a Corporate Update on August 14NASDAQ:NMTCNeuroOne Medical Technologies Corporation
25/07/202314:00GlobeNewswire Inc.NeuroOne Medical Technologies Corporation Announces Pricing of Public Offering of Common StockNASDAQ:NMTCNeuroOne Medical Technologies Corporation
24/07/202322:03GlobeNewswire Inc.NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common StockNASDAQ:NMTCNeuroOne Medical Technologies Corporation
12/06/202314:35GlobeNewswire Inc.NeuroOne® Submits 510(k) Application to FDA for OneRF™ Ablation System NASDAQ:NMTCNeuroOne Medical Technologies Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:NMTC
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network